First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD).

Source:http://linkedlifedata.com/resource/pubmed/id/20042346

Download in:

View as

General Info

PMID
20042346